Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Perfusion
Recent findings in perfusion described by H.J. Rupprecht and colleagues
May 14th, 2008
According to recent research published in the journal Herz, "Direct percutaneous coronary intervention (PCI) can be considered the gold standard of reperfusion therapy. For patients with need for transfer, the question of antithrombotic pretreatment arises." "Concept of Facilitated PCI: With the concept of facilitated PCI the advantages of fibrinolysis, namely the rapid and ubiquitous availability, should be combined with the advantages of immediate PCI. With a pretreatment using fibrinolytics, glycoprotein IIb/IIIa inhibitors (GPI) or the combination of both (in that case a fibrinolytic in half dosage only),it was aimed to achieve reperfusion before a planned PCI....
Source: Medical Patent Law Weekly (2008-05-14)
|
